A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins30 enrolled

Overview

Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Tobacco Use Disorder Head and Neck Neoplasms Thoracic Neoplasms Radiation

Interventions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 105 Years

Medical Language ↔ Plain English

Inclusion Criteria: * New diagnosis of head and neck or thoracic (including lung) cancer * Undergoing radiation at Johns Hopkins Radiation Oncology for 5 or more weeks * English-speaking and able to provide informed consent * Smoked any cigarettes in previous 14 days Exclusion Criteria: * Palliative radiation * Undergoing stereotactic radiosurgery * Pregnant or breastfeeding

Outcomes

Primary Outcomes

Smoking cessation

Smoking cessation will be defined as BOTH (1) self-reported 7-day abstinence from smoking and (2) exhaled carbon monoxide level of 8 or lower as biochemical confirmation of abstinence.

Time frame: 8 weeks